KRISTIN LUNDSTEN: Open Payments
NPI 1104377365 · EAST PROVIDENCE, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$201 in 10 payments from 9 companies in 2025. Trend: 2023 $243 · 2024 $180 · 2025 $201
Food & beverage: $201
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 1 | $39 |
| Lilly USA, LLC | 1 | $35 |
| Braeburn Inc. | 1 | $25 |
| Vanda Pharmaceuticals Inc. | 1 | $23 |
| Indivior Inc. | 1 | $21 |
| Sage Therapeutics, LLC | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| ABBVIE INC. | 1 | $14 |
| Corium, LLC | 2 | $6 |
Products named: INGREZZA, ZEPBOUND, BRIXADI, FANAPT, SUBLOCADE, ZURZUVAE, REXULTI, VRAYLAR.
Industry payments across RI — which companies pay providers there.
